Patients with FAP2 usually present a smaller number of adenomas (10–100, similar to an attenuated form of FAP1), serrated polyps, and an increased risk of other cancers (duodenum, ovary, bladder, breast, and endometrium). The gene discussed is PTPN13; the disease is adenoma.